New York City, NY -- (SBWIRE) -- 12/18/2013 -- StockMarketIntel.com issues a special report on the following stocks: Sigma Labs Inc (OTCMKTS:SGLB), Softbank Corp. (Japan) (OTCMKTS:SFTBY), Cannabis Science Inc (OTCMKTS:CBIS), Wynn Macau Ltd. (OTCMKTS:WYNMY)
Sigma Labs Inc (OTCMKTS:SGLB) declined -5.74%, trading on 4.17 million shares, to end the trade at $0.179. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.01 and was moved to the maximum level of $0.28. The stock changed hands in a range of $0.18 to $0.19, bringing its market capitalization to about $99.40 million. Sigma Labs, Inc. engages in the development and commercialization of manufacturing and materials technologies, and R&D solutions. It also focuses on commercializing technologies and products in various industry sectors, such as in process quality assurance for manufacturing; aerospace and defense manufacturing; additive manufacturing; active protection systems for defending light armored vehicles; advanced materials for munitions; advanced materials for sporting goods; advanced manufacturing technologies; and dental implant and biomedical prosthetics technologies.
Has SGLB Found The Bottom and Ready To Move Up? Find Out Here
Softbank Corp. (Japan) (OTCMKTS:SFTBY) added 0.35%, to complete the trading session at $42.60, with a total volume of 135,668 shares. The stock, on average, trades on a volume of 304,977 shares. In the past 52 weeks, the share price has not declined below $16.53 and above $44.17. It floated in a range of $42.42 to $42.83 during the last trading session, with a beta value of 1.11. Its market capitalization now moved to about $101.94 billion.
What was the Moving Force behind SFTBY on Bullish Run? Read This Research Report
Cannabis Science Inc (OTCMKTS:CBIS) recorded a gain of 5.19% and was in a range of $0.03-$0.03 before closing at $0.0324. The share price hit its 52-week low of $0.03 and $0.12 was the best price. The stock completed the day with a total volume of 2.30 million shares, versus an average volume of 2.97 million shares. Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. It primarily focuses on developing medications to treat autism, blood pressure, cancer and cancer side effects, HIV, and other illnesses, including general health maintenance.
For How Long CBIS will fight for Profitability? Read This Trend Analysis report
Wynn Macau Ltd. (OTCMKTS:WYNMY) added 3.75% yesterday, bringing its market capitalization around $23.60 billion. The total number of shares that changed hands during the session was 70,452 shares, as compared to average trading volume of 21,518 shares. The share price, after opening at $46.52, made a high of $47.25 and hovered above $46.35 to end the day at $47.19.
For How Long WYNMY Gloss will Attract Investors? Find out via this report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)